Vitruvian Partners

About Vitruvian Partners

Vitruvian Partners is a London-headquartered growth buyout firm with approximately €20 billion of assets under management as of October 2024, with offices in London, Munich, Madrid, Stockholm, Luxembourg, Miami, San Francisco, Mumbai, Shanghai and Singapore. The firm was founded in 2006 by former partners of Apax Partners, BC Partners and Bridgepoint Capital as an independent partner-owned LLP focused on growth buyout and growth capital in higher-growth mid-market companies across Europe, North America and Asia. Vitruvian Investment Partnership V closed at its €7.3 billion hard cap in September 2024.

Investment thesis

Vitruvian deploys capital through five successor flagship vehicles (VIP I through VIP V) plus thematic co-invest vehicles into pan-regional growth-buyout opportunities across technology and software, fintech, healthcare technology, internet and consumer, business services and enterprise applications. The firm's sector-tilted approach toward technology-driven categories has produced a track record of scaling category-leaders including Wise, Pine Labs and Ebury, with 10 unicorns and 18 IPOs across the portfolio history. Capital deployment combines majority and significant minority equity tickets alongside founder and management teams, with sector specialisation enabling deep partnership with technology-led businesses scaling internationally.

Recent activity

Recent realised exits include realisations across financial services and fund administration (2026), software and technology (2025) and fintech across 2024-2025. Recent acquisitions include Aquabyte (aquaculture technology, 2025), DeepIntent (healthcare adtech, 2025) and Azul Systems (software, 2025). Vitruvian continues to deploy capital across its VIP V vintage while pursuing selective bolt-on M&A and follow-on investments across the existing portfolio. Detailed buyer names and multiple data available on Pro at €29/month.